1. Home
  2. UG vs ANEB Comparison

UG vs ANEB Comparison

Compare UG & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UG
  • ANEB
  • Stock Information
  • Founded
  • UG 1942
  • ANEB 2020
  • Country
  • UG United States
  • ANEB United States
  • Employees
  • UG N/A
  • ANEB N/A
  • Industry
  • UG Package Goods/Cosmetics
  • ANEB Biotechnology: Pharmaceutical Preparations
  • Sector
  • UG Consumer Discretionary
  • ANEB Health Care
  • Exchange
  • UG Nasdaq
  • ANEB Nasdaq
  • Market Cap
  • UG 43.9M
  • ANEB 41.2M
  • IPO Year
  • UG N/A
  • ANEB 2021
  • Fundamental
  • Price
  • UG $9.55
  • ANEB $1.59
  • Analyst Decision
  • UG
  • ANEB Buy
  • Analyst Count
  • UG 0
  • ANEB 1
  • Target Price
  • UG N/A
  • ANEB $8.00
  • AVG Volume (30 Days)
  • UG 19.4K
  • ANEB 5.5K
  • Earning Date
  • UG 11-08-2024
  • ANEB 11-13-2024
  • Dividend Yield
  • UG 6.28%
  • ANEB N/A
  • EPS Growth
  • UG 38.11
  • ANEB N/A
  • EPS
  • UG 0.76
  • ANEB N/A
  • Revenue
  • UG $12,312,275.00
  • ANEB N/A
  • Revenue This Year
  • UG N/A
  • ANEB N/A
  • Revenue Next Year
  • UG N/A
  • ANEB N/A
  • P/E Ratio
  • UG $12.59
  • ANEB N/A
  • Revenue Growth
  • UG 11.51
  • ANEB N/A
  • 52 Week Low
  • UG $6.75
  • ANEB $1.46
  • 52 Week High
  • UG $16.25
  • ANEB $3.30
  • Technical
  • Relative Strength Index (RSI)
  • UG 24.16
  • ANEB 41.55
  • Support Level
  • UG $9.00
  • ANEB $1.46
  • Resistance Level
  • UG $10.65
  • ANEB $1.73
  • Average True Range (ATR)
  • UG 0.84
  • ANEB 0.11
  • MACD
  • UG -0.32
  • ANEB -0.02
  • Stochastic Oscillator
  • UG 10.68
  • ANEB 26.20

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.

Share on Social Networks: